CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 100 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07016282
NCT07016282N/AActiveOn TrackUpdated 9mo ago

Simulated and Synthetic Health Data: Improving Clinical Research on Rare Diseases. A Real-World Data Simulation of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trials. A Retrospective, Observational Study

Mario Negri Institute for Pharmacological Research·observational·Posted Jun 11, 2025·Updated Sep 2, 2025

In Brief

An observational study for Autosomal Dominant Polycystic Kidney Disease (ADPKD). Active but no longer recruiting, targeting 100 participants across 2 sites in 2 countries.

Detailed Summary

This is a no-profit, retrospective observational study involving real-world data (RWD), retrieved from ADPKD-related electronic health records stored at Mario Negri Institute IRCCS. RWD will be used to generate simulated and synthetic datasets, using AI tools. RWD and generated data (GD) will be used to conduct three virtual RCTs, which main outcome is change in Total Kidney Volume (TKV). Statistical tests will be performed to assess quality and privacy preservation of GD compared with RWD. GD will be also evaluated in exploratory sample size estimations.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly, Sweden
Collaborators--

Timeline

N/AActive
20262027
First PostedJun 11, 2025
Enrollment StartJun 12, 2025
Primary CompletionJun 1, 2027
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 1.1 years agoPrimary completion in 11 months